breadcrumb-bg

News

Smart-Health News

19 June, 2023

Leukemia spread fueled by messenger particles

Tiny packets of molecular cargo shed by cancer cells seed the foundations for metastasis at distant sites in the body.

Read more

01 June, 2023

KAUST and PATH sign Memorandum of Understanding

The partnership seeks to leverage expertise in vaccine development, digital health systems, and biobanking to advance global health equity and foster innovative solutions in Saudi Arabia and beyond.

Read more

09 May, 2023

Using plants as factories for green drug production

Biopharming technique yields cost-effective and environmentally friendly antimicrobial peptides.

Read more

30 April, 2023

Early pathogen detection: Collaboration speeds up sensor development

Prof. Sahika Inal and her team are collaborating closely with Ashraf Dada, Fatima Alhamlan and co-workers at King Faisal Specialist Hospital and Research Centre (KFSH&RC) in Saudi Arabia. The aim of the partnership is to help develop and trial bioelectronic sensors that will aid in cheap, accurate and rapid pathogen detection.

Read more

17 April, 2023

Single-atom catalyst for cancer detection

An electronic sensor based on individual atoms anchored to MXene nanomaterials can detect tumor-specific biomarkers.

Read more

16 April, 2023

First-of-its-kind Kingdom stem cell study sheds light on Klinefelter syndrome

In a research partnership between KAUST, King Abdulaziz University, Jeddah (KAU) and King Abdulaziz University Hospital, Jeddah (KAUH), scientists have conducted a first-of-its-kind study in the Kingdom that compares stem cells derived from a unique cohort of Saudi Klinefelter patients with a group of North American and European descent.

Read more

In the media

24 August, 2022

"Sticky" stem cells make for better transplants

Enhancement of adhesion molecules improves the ability of blood-forming stem cells to take root in transplant recipients.

Read more

16 August, 2022

RNA-based approach identified for treatment of premature aging and associated diseases

KAUST scientists are researching RNA-based approaches to treat progeria, an early aging disease that affects children and adolescents.

Read more

16 August, 2022

Cell mapping close to the bone

KAUST bioscientists are developing new methods to combine single-cell sequencing datasets, which will help to improve understanding of cellular identity and function. The team has used the method to study the bone marrow microenvironment in greater detail.

Read more

28 July, 2022

KAUST visiting professor collaborates with KAUST faculty and staff to study Saudi air quality

KAUST Smart-Health Initiative has been honored to host Junfeng (Jim) Zhang at KAUST during his sabbatical. Prof. Zhang has been developing several air pollution studies in collaboration with KAUST faculty and staff.

Read more

03 July, 2022

Stem cells reveal underpinnings of rare immune disease

Abnormal protein tied to Wiskott-Aldrich syndrome found to control gene splicing.

Read more

29 June, 2022

Turning up the heat to unlock Cas13's potential

A newly identified heat-stable Cas13 enzyme could lead to improved diagnostics and new biotechnological applications.

Read more

28 June, 2022

Bone formation comes down to the nanowire

Nanotechnology that accelerates the transition of stem cells into bone could advance regenerative medicine.

Read more

24 May, 2022

AI helps diagnose post-COVID lung problems

A new AI diagnostic tool developed by KAUST scientists allows doctors to visualize lung damage caused by COVID-19 in more detail.

Read more

25 January, 2022

كاوست: مبادرة الصحة الذكية ترفع معايير رعاية المرضى

Read more

23 November, 2021

First MD-Ph.D. program in Saudi Arabia

Top medical students from AlFaisal University will undertake their Ph.D. degree at KAUST to obtain the necessary training needed to conduct basic research and the implementation of smart-health tools and methods in the Saudi healthcare delivery system.

Read more

15 November, 2021

MD-Ph.D. Program

The goal of this program is to offer Saudi and resident students of medicine at Al-Faisal University state-of-the-art educational and research facilities. The program is tailored to those who aspire to build their careers as physician-scientists and will be the leaders of tomorrow.

Read more

19 September, 2021

KAUST-developed COVID-19 test kit ready for University community

President Chan receives the Kingdom’s first, KAUST-developed COVID-19 RT-PCR test, processed by KAUST startup Noor DX.

Read more

25 August, 2021

How Saudi Arabia plans to make up to 7m vaccine doses a year

The man behind the kingdom’s vaccine-development center is building an entire industry from scratch.

Read more

08 June, 2021

Workshop highlights mammalian brain research

Global experts and participants in the field of brain research gathered online for a two-day conference, Integrative modeling of brain energy metabolism, presented by the Blue Brain Project Alliance.

Read more

02 June, 2021

Transistors spot single SARS-CoV-2 spike proteins

A new sensor, based on organic transistors, combines speed and accuracy in detecting single-molecule antigens belonging to the viruses that cause COVID-19 and MERS.

Read more

15 April, 2021

Magistretti features at U.S.-K.S.A. Business Forum

KAUST Distinguished Professor Pierre Magistretti, Director of the newly launched Smart-Health Initiative, took part in a virtual event put on by the U.S. Chamber of Commerce and the Kingdom of Saudi Arabia Ministry of Investment.

Read more

05 April, 2021

Virtual launch of Smart-Health Initiative

KAUST has recently launched a multidisciplinary scientific and clinical research and innovation health initiative dubbed the KAUST Smart-Health Initiative (SHI).

Read more

02 February, 2021

A healthy boost to precision medicine in KSA

The Smart Health Initiative aims to enhance Saudi Arabia's capabilities in what Magistretti describes as precision medicine.

Read more

20 December, 2020

KAUST and Johnson & Johnson sign dengue fever research collaboration agreement

KAUST announced a collaboration with Janssen Pharmaceutical Companies of Johnson & Johnson to explore opportunities for research and innovation in the area of neglected tropical diseases, with a focus on dengue fever.

Read more

08 November, 2020

KAUST startup tackles COVID using AI and robotics

The COVID-19 pandemic has activated vital innovation and R&D initiatives to tackle the crippling effects, health ramifications, and overall impact of the coronavirus on global societies and economies.

Read more